A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CB1R / cannabinoid receptor 1

[Related PubMed/MEDLINE]
Total Number of Papers: 511
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CB1R  (>> Co-occurring Abbreviation)
Long Form:   cannabinoid receptor 1
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation. ACPA, BLM, ECM, TGF-beta
2022 Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation via a potential NOX/CaMKII mechanism. AF, Ang II, CB2R, ECS, NOX2
2022 Acute cannabinoids impair association learning via selectively enhancing synaptic transmission in striatonigral neurons. DMS, MSNs
2022 Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes. CB2R, T1DM
2022 Attenuation of oleoylethanolamide-induced reduction of alcohol consumption in adult rats exposed intermittently to alcohol during adolescence. OEA
2022 Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors. 5-HT4R, CB2R, IBD, ISE, MTAs, PPARgamma
2022 Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice. ACEA, CB2R, VMR
2022 Cannabinoid Receptor 1 Is Required for Neurodevelopment of Striosome-Dendron Bouquets. ---
2022 Cannabinoid Receptor Type 1 regulates growth cone filopodia and axon dispersion in the optic tract of Xenopus laevis tadpoles. RGCs
10  2022 Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome. CD, ECS, WBS
11  2022 Cannabinoid Type 1 Receptors in the Basolateral Amygdala Regulate ACPA-Induced Place Preference and Anxiolytic-Like Behaviors. ACPA, BLA, CPP, i.p, THC
12  2022 Cannabinoids and terpenes for diabetes mellitus and its complications: from mechanisms to new therapies. CBD, ECS, THCV
13  2022 CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects. FSTs, KO, WT
14  2022 CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review. CB, CB2R, ECS, TM, TRPV1
15  2022 CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity. ---
16  2022 Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2. CB2R, GPCRs
17  2022 Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist. BBB
18  2022 Chronic cannabis use affects cerebellum dependent visuomotor adaptation. ---
19  2022 Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) "Cis-On" Agonist. CBRs, hCB1R
20  2022 Development of high-affinity fluorinated ligands for cannabinoid subtype 2 receptor, and in vitro evaluation of a radioactive tracer for imaging. CB2R, CNS, PET
21  2022 Diet-Induced Gut Barrier Dysfunction Is Exacerbated in Mice Lacking Cannabinoid 1 Receptors in the Intestinal Epithelium. DIO, LI, WD
22  2022 Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic Dermatitis. AD, AD, ECS, GPR55, PPARalpha, TRPV1
23  2022 Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats. 2-AG, AEA, CB2R, CGRP, EM-2, ETJ, FAAH, i.c.v, i.p, SP
24  2022 Electroacupuncture Reduces Anxiety Associated With Inflammatory Bowel Disease By Acting on Cannabinoid CB1 Receptors in the Ventral Hippocampus in Mice. EA, IBD, vHPC
25  2022 Electroacupuncture relieves visceral hypersensitivity through modulation of the endogenous cannabinoid system. CRD, EA, ECS, FAAH, MAGL, TNBS, VH, VMR
26  2022 Estrogen dampens central cannabinoid receptor 1-mediated neuroexcitation and pressor response in conscious female rats. BP, HR, nNOS, OVXE2, RVLM
27  2022 Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma. p-ERK
28  2022 Long term effects of 24-h-restraint stress on the connectivity and structure of interneurons in the basolateral amygdala. BLA, PV
29  2022 Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures. ER, GPCRs, H-bond, TM
30  2022 Modulation of the CB1 cannabinoid receptor has potential therapeutic utility in the 3-acetylpyridine cerebellar ataxia rat model. WIN
31  2022 Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge. SUDs
32  2022 New Subregions of the Mouse Entopeduncular Nucleus Defined by the Complementary Immunoreactivities for Substance P and Cannabinoid Type-1 Receptor Combined with Distributions of Different Neuronal Types. EPN, LHb, SNr, SP
33  2022 Oleamide Reduces Mitochondrial Dysfunction and Toxicity in Rat Cortical Slices Through the Combined Action of Cannabinoid Receptors Activation and Induction of Antioxidant Activity. 3-NP, CB2R, OEA
34  2022 Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function. DKD, GLUT2, mTORC1, RPTCs
35  2022 Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity. BW, CYP, ECS, LUTSs, TNF-alpha, VSA
36  2022 Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism. ---
37  2022 Probable role of the hyperpolarization-activated current in the dual effects of CB1R antagonism on behaviors in a Parkinsonism mouse model. DA, HCN, i.c.v, NMS, PD, VTA, WIN
38  2022 Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases. PET
39  2022 Release of Endocannabinoids into the Cerebrospinal Fluid during the Induction of the Trigemino-Hypoglossal Reflex in Rats. 2-AG, AEA, CB2R, CSF, ECS, ETJ
40  2022 Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment. METH, NOR, WIN
41  2022 SGIP1 modulates kinetics and interactions of the cannabinoid receptor 1 and G protein-coupled receptor kinase 3 signalosome. BRET, GRKs
42  2022 Spatial organization of neuron-astrocyte interactions in the somatosensory cortex. ---
43  2022 Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CB1R) Receptor with Reduced Lipophilicity. DIO
44  2022 The Effect of Exercise Training and Royal Jelly on Hippocampal Cannabinoid-1-Receptors and Pain Threshold in Experimental Autoimmune Encephalomyelitis in Rats as Animal Model of Multiple Sclerosis. EAE, ET, HC, MS, PT, RJ
45  2022 The intersection of astrocytes and the endocannabinoid system in the lateral habenula: on the fast-track to novel rapid-acting antidepressants. LHb
46  2021 (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice. STZ
47  2021 Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture. EA, eCB, MCAO
48  2021 An Autonomous Cannabinoid System in Islets of Langerhans. ECs, ECS
49  2021 Anti-LINGO-1 antibody ameliorates cognitive impairment, promotes adult hippocampal neurogenesis, and increases the abundance of CB1R-rich CCK-GABAergic interneurons in AD mice. AD, AHN, anti-LINGO-1 antibody, LINGO-1
50  2021 Basolateral amygdala CB1 receptors gate HPA axis activation and context-cocaine memory strength during reconsolidation. BLA
51  2021 Bifunctional mu opioid and sigma1 receptor ligands as novel analgesics with reduced side effects. MOR, NMDAR, sigma1R
52  2021 Binge sucrose-induced neuroadaptations: A focus on the endocannabinoid system. BED, CPP, ECS
53  2021 Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression. ---
54  2021 Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Abeta pathology models. AD, C. elegans, CaMKII, CBD, FAAH
55  2021 Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum. MP, TRPA1, TRPV1
56  2021 Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox. CKD, ECS
57  2021 Cannabinoid Receptor Type 1 (CB1R) Expression in Limbic Brain Structures After Acute and Chronic Seizures in a Genetic Model of Epilepsy. ECS, WAR
58  2021 Cannabinoid receptor type 1 antagonists alter aspects of risk/reward decision making independent of toluene-mediated effects. mPFC
59  2021 Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression. CB2R
60  2021 Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment. AS, AuK, CBD
61  2021 CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats. CIH, HE, NC, OSA, PAS, Ri
62  2021 CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators. ---
63  2021 CB1R activation in nucleus accumbens core promotes stress-induced reinstatement of cocaine seeking by elevating extracellular glutamate in a drug-paired context. CPP, NA
64  2021 CB1Rs in VMH neurons regulate glucose homeostasis but not body weight. CB1Rs, VMH
65  2021 Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy. CBD
66  2021 Chronic Marijuana Consumption Leading to High-Grade Atrioventricular Block in a Young Male. AV, EPS, HV
67  2021 Chronic marijuana usage by human pancreas donors is associated with impaired islet function. ---
68  2021 Collagen VI Regulates Motor Circuit Plasticity and Motor Performance by Cannabinoid Modulation. BPN, CTD, eCB
69  2021 Contrasting Roles of Ang II and ACEA in the Regulation of IL10 and IL1beta Gene Expression in Primary SHR Astroglial Cultures. Ang, AT1R, SHR
70  2021 Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure. ago-PAM, hCB1R, IOP, SAR
71  2021 Diabetes and Cannabinoid CB1 receptor deficiency promote similar early onset aging-like changes in the skin. CB1R-KO, ROS, WT
72  2021 Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy. ago-PAM
73  2021 Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human. 2-AG, AEA, ECS, ECs, WAT
74  2021 Experience-Dependent Inhibitory Plasticity Is Mediated by CCK+ Basket Cells in the Developing Dentate Gyrus. CCK, EC, EE, GCs, PV
75  2021 Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist. betaArr2, CNS, KO
76  2021 In vivo Bidirectional Modulation of Cannabinoid on the Activity of Globus Pallidus in Rats. CB2R, EBST, GP
77  2021 Inhibition of CB1 receptor alleviates electroconvulsive shock-induced memory impairment by regulating hippocampal synaptic plasticity in depressive rats. 2-AG, CMS, ECS, ECT, LTP, OFT, SPT
78  2021 Localisation of Cannabinoid and Cannabinoid-Related Receptors in the Horse Ileum. 5-HT1aR, PPARalpha
79  2021 Manipulating Pharmacodynamic Efficacy with Agonist + Antagonist Mixtures: In Vitro and In Vivo Studies with Opioids and Cannabinoids. MOR
80  2021 Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases. CB2R, CNS
81  2021 mGluR5-Mediated eCB Signaling in the Nucleus Accumbens Controls Vulnerability to Depressive-Like Behaviors and Pain After Chronic Social Defeat Stress. 2-AG, CHPG, CSDS, eCB, MDD, mGluR5, MTEP, NAc
82  2021 Microglial Cannabinoid Type 1 Receptor Regulates Brain Inflammation in a Sex-Specific Manner. ---
83  2021 Mutual assistance of nucleus accumbens cannabinoid receptor-1 and orexin receptor-2 in response to nicotine: a single-unit study. NAc, OX2R
84  2021 Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice. 2-AG, CLEM, D2R, DA, LH, NAc, Ox-A, OX1R, PLC, VTA, WT
85  2021 Peripheral CB1R as a modulator of metabolic inflammation. ---
86  2021 Peripheral Hybrid CB1R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis. iNOS, KO
87  2021 Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases. CB2R
88  2021 Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development. ECS, FAAH, MAGL, PET
89  2021 Presence of the Endocannabinoid System in the Inferior Pulvinar of the Vervet Monkey. eCB, PI
90  2021 Renal Proximal Tubule Cell Cannabinoid-1 Receptor Regulates Bone Remodeling and Mass via a Kidney-to-Bone Axis. DKD, EPO, RPTCs
91  2021 Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways. HIR, NF-kappaB, TNF-alpha
92  2021 Social Experience Regulates Endocannabinoids Modulation of Zebrafish Motor Behaviors. DAGL, ECS
93  2021 The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice. 2-AG, FAAH, MAGL
94  2021 The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain: A Review. CB2R, DPN
95  2021 The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats. EPM, NTG, OF, Orx1R, vlPAG
96  2021 Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1. BDNF, GLP-1, HFSD, LPS, PGN, STZ, TLR4, VD, ZO-1
97  2020 (m)RVD-hemopressin (α) and (m)VD-hemopressin (α) improve the memory-impairing effect of scopolamine in novel object and object location recognition tasks in mice. AD, Hp
98  2020 Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cellsand Reduces Acute Inflammation and Organ Injury. Delta9-THC
99  2020 Activation of CB1R-Dependent PGC-1alpha Is Involved in the Improved Mitochondrial Biogenesis Induced by Electroacupuncture Pretreatment. EA, MCAO, mtDNA, PGC-1alpha, siRNA
100  2020 Adverse effects of Delta9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development. THC